Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1140 results found. Search for [ USFDA ]

Results 1 to 21 of 1140
BusinessToday.In
April 5, 2021
Over 91.15% of patients treated with PegIFN were found to be RT PCR negative by day 7 as compared to 78.90 per cent on the 'standard of care' arm; PegIFN reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate COVID-19 patients


Sumant Banerji
March 25, 2021
Available in 10ml, 50ml, 100ml and 250ml pack sizes, it is priced between Rs 60 and 275 and is significantly more expensive than the regular hand sanitisers in the market


BusinessToday.In
March 5, 2021
Shares of Wipro, Heranba Industries, Indiabulls Housing, Unichem Labs, Jagran Prakashan and others will be in focus in Friday's trading session


PTI
March 3, 2021
Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing


PTI
March 2, 2021
The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray


BusinessToday.In
February 19, 2021
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE


BusinessToday.In
February 19, 2021
Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers


BusinessToday.In
February 12, 2021
Stock Market News Updates Today: Earlier today, Sensex hit a record high of 51,804 and Nifty hit a lifetime high of 15,243


BusinessToday.In
February 11, 2021
Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


PTI
February 9, 2021
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations


Joe C Mathew
February 9, 2021
The enhanced trade partnership is expected to address several trade barriers that currently exist. Britain is keen to see India reduces barriers on import of agriculture and food items


Nidhi Singal
February 9, 2021
Approximately 1.3 million EVs were sold in both China and Europe in 2020, four times the EV sales in the US


PB Jayakumar
February 9, 2021
Rhizen has retained commercialisation rights for India while also being the manufacturing and supply partner for Umbralisib. Alembic owns 50 per cent stake in Rhizen


BusinessToday.In
February 7, 2021
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.


PTI
February 7, 2021
The affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc


BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


BusinessToday.In
January 25, 2021
Stocks to watch today on January 25: RIL, YES Bank, JM Financial, Gland Pharma, JSW Steel, Tata Motors among others are the top stocks to watch out for in Monday's trading session


PTI
January 23, 2021
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing


PTI
January 10, 2021
The drug firm has manufactured the affected lot at its Kurkumbh facility in Maharashtra and then supplied to its New Jersey-based subsidiary


BusinessToday.In
January 9, 2021
Coronavirus pandemic: Without the uniform implementation of effective face masking and strict social distancing, epidemics could quickly worsen as these variants spread and become predominant, said the task force


PAGES 1 OF 57  12345